{
    "data": [
        {
            "title": "Fossil Group's UK subsidiary to hold a Plan Meeting on Nov 6, 2025 for $150 million debt restructuring. For more details visit Globenewswire.com",
            "id": "6f4c315b-69d9-444e-b882-321411c26a9f",
            "description": "On October 30, 2025, in Richardson, Texas, Fossil (UK) Global Services Ltd, a subsidiary of Fossil Group, Inc. (NASDAQ: FOSL), made an announcement regarding their upcoming meeting. The High Court of Justice of England and Wales issued an order on October 15, 2025, known as the Convening Order, concerning Fossil's US $150,000,000 7.00% Senior Notes due November 30, 2026. A single gathering, the Plan Meeting, is scheduled for November 6, 2025, for the Plan Creditors to discuss and potentially approve the proposed restructuring plan under the Companies Act 2006. This meeting aims to address the restructuring of the Notes with the possibility of alterations, additions, or conditions as mandated by the Court.",
            "link": "https://www.markets.news/headlines/6f4c315b-69d9-444e-b882-321411c26a9f",
            "pub_date": "2025-10-31 05:04:06",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Trisura Group Ltd. to release Q3 2025 results and hold earnings call, announced in Toronto on Oct. 30, 2025.",
            "id": "6576f4a4-a968-4b73-b452-6822f116a121",
            "description": "Trisura Group Ltd., a prominent specialty insurer (TSX: TSU), has revealed that it will be disclosing its third quarter 2025 results and hosting an earnings conference call on a specific date.",
            "link": "https://www.markets.news/headlines/6576f4a4-a968-4b73-b452-6822f116a121",
            "pub_date": "2025-10-31 05:04:14",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Corbus Pharmaceuticals plans public offering, selling shares or warrants, all securities to be sold by company. Market conditions may affect completion.",
            "id": "16fec4d7-623a-4b76-8ceb-ada685b053fc",
            "description": "In NORWOOD, Massachusetts, a company named Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) has revealed their intention to conduct a registered public offering. The company, focusing on oncology and obesity, plans to offer shares of its common stock or pre-funded warrants to certain investors for the purchase of common stock. All securities in the offering will be sold by Corbus. The completion of the offering, as well as its size and terms, is contingent on market conditions with no guarantee of finalization or specific details provided at the moment.",
            "link": "https://www.markets.news/headlines/16fec4d7-623a-4b76-8ceb-ada685b053fc",
            "pub_date": "2025-10-31 05:04:17",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "6d4b74d4-5fc6-46b2-bee6-d1b85ad935fb",
            "description": "DBV Technologies appoints Philina Lee, Ph.D. to its Board of Directors.",
            "link": "https://www.markets.news/headlines/6d4b74d4-5fc6-46b2-bee6-d1b85ad935fb",
            "pub_date": "2025-10-31 05:04:20",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Olema Oncology to present trial-in-progress for Phase 3 OPERA-02 Trial of Palazestrant + Ribociclib at SABCS 2025 in San Antonio, TX, focusing on ER+, HER2- advanced breast cancer.",
            "id": "6a629194-edd2-4b68-bbe6-1d801d1d8040",
            "description": "Olema Pharmaceuticals, Inc. shared news today that they will be showcasing a trial-in-progress poster at the 2025 San Antonio Breast Cancer Symposium. The Phase 3 OPERA-02 trial focuses on evaluating palazestrant alongside ribociclib for frontline treatment of estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Olema, also known as Olema Oncology and traded as Nasdaq: OLMA, is a clinical-stage biopharmaceutical company specializing in targeted therapies for breast cancer. The symposium is scheduled for December 9-12, 2025, in San Antonio, TX.",
            "link": "https://www.markets.news/headlines/6a629194-edd2-4b68-bbe6-1d801d1d8040",
            "pub_date": "2025-10-31 05:04:21",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "CA technology helps primary care physicians in underserved areas diagnose earlier, reducing hospitalizations.",
            "id": "6215b8d6-5ca8-4b5b-8454-b9f006af96e1",
            "description": "A recent whitepaper reveals the effectiveness of Care Assistants (CA) in empowering primary care teams in limited resource environments to successfully prevent, detect, and handle chronic diseases. This valuable resource demonstrates how CAs contribute to enhancing healthcare in areas facing scarcity by aiding in the management of chronic diseases. The whitepaper provides insights into how CAs play a crucial role in improving healthcare outcomes and reducing the burden of chronic illnesses on primary care teams. It highlights the impact of CAs in enabling healthcare providers to better address the needs of patients in resource-constrained settings, leading to a significant improvement in overall health outcomes. This innovative approach showcases how CAs can make a substantial difference in enhancing healthcare delivery for patients with chronic conditions.",
            "link": "https://www.markets.news/headlines/6215b8d6-5ca8-4b5b-8454-b9f006af96e1",
            "pub_date": "2025-10-31 05:04:25",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "CN to release Q3 2025 financial report on Oct 31, 2025, at 7:30 am Eastern Time. (TSX: CNR) (NYSE: CNI)",
            "id": "1f721411-f673-419b-bd6c-3d6777b8a9b8",
            "description": "On October 30, 2025, CN (TSX: CNR) (NYSE: CNI) announced that they will release their financial and operating results for the third quarter of 2025 at 7:30 a.m. Eastern Time on October 31, 2025.",
            "link": "https://www.markets.news/headlines/1f721411-f673-419b-bd6c-3d6777b8a9b8",
            "pub_date": "2025-10-31 05:04:27",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "AAON appoints Roberto Giacomelli as Senior VP of Operations on 10/30/25, enhancing its executive team.",
            "id": "6de8a6ab-3e15-4230-abb7-9e26377661b6",
            "description": "In Tulsa, Oklahoma on October 30, 2025, AAON, Inc. announced the appointment of Roberto Giacomelli as the new Senior Vice President of Operations. AAON is recognized for its high-performance and energy-efficient HVAC solutions. The company, listed on NASDAQ as AAON, continues to strengthen its executive team with this strategic addition.",
            "link": "https://www.markets.news/headlines/6de8a6ab-3e15-4230-abb7-9e26377661b6",
            "pub_date": "2025-10-31 05:05:17",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Curavit recruits half of participants for The APPROVE Trial two months early, reaching milestone.",
            "id": "42e97a69-0325-4b1f-89a0-577b273fc537",
            "description": "In a significant development, Curavit Clinical Research, known as \"The Innovation CRO,\" based in Boston and Columbia, Md., as well as Galway, Ireland, has achieved a notable milestone. They have successfully enlisted 50% of the required participants for The APPROVE Trial, a randomized trial, well ahead of the initial schedule by a full two months. This accomplishment showcases the efficiency and effectiveness of their recruitment efforts.",
            "link": "https://www.markets.news/headlines/42e97a69-0325-4b1f-89a0-577b273fc537",
            "pub_date": "2025-10-31 05:05:20",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "ATS to participate in Baird 2025 Global Industrial Conference with CEO Ryan McLeod & CFO Anne Cybulski on Nov. 11, 2025, in Chicago at 12:35 p.m. (CT). Webcast link at investor site.",
            "id": "f68f5b7e-f1e5-4724-a1e6-fc3bd27bb4a5",
            "description": "ATS Corporation (TSX: ATS) (NYSE: ATS) disclosed that Ryan McLeod, the Interim CEO, and Anne Cybulski, the Interim CFO, are set to partake in the Baird 2025 Global Industrial Conference in Chicago on November 11, 2025. ATS will deliver a presentation at 12:35 p.m. (CT) during the event. The live event's webcast link will be accessible on the Investor Relations site at https://investors.atsaut.",
            "link": "https://www.markets.news/headlines/f68f5b7e-f1e5-4724-a1e6-fc3bd27bb4a5",
            "pub_date": "2025-10-31 05:05:24",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Roku beats Q3 earnings with $1.211 billion net revenue, positive operating income first time since 2021.",
            "id": "b91e349d-6f20-4b1f-a969-72d41a951a84",
            "description": "Roku Inc (NASDAQ: ROKU) released its third-quarter financial results after the market closed. The company reported a net revenue of $1.211 billion, marking a 14% increase from the previous year and surpassing the Street's consensus estimate of $1.206 billion sourced from Benzinga Pro. Platform revenue for the third quarter reached $1.06 billion, rising by 17% year-over-year, while devices revenue was at $146.0 million, showing a 5% decrease. Roku attributed the growth in platform revenue to successful streaming services distribution and video advertising activities. Earnings per share for the third quarter were 16 cents, outperforming the Street's consensus forecast.",
            "link": "https://www.markets.news/headlines/b91e349d-6f20-4b1f-a969-72d41a951a84",
            "pub_date": "2025-10-31 04:56:45",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "BioVaxys increases life offering to $2M // Not available in the US // Vancouver, BC, Oct. 30, 2025 - BioVaxys Technology Corp. upsizes private placement.",
            "id": "8ee7e826-e91d-41b1-8c4e-52d231886e32",
            "description": "VANCOUVER, BC - On October 30, 2025, BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (referred to as \"BioVaxys\" or the \"Company\") revealed a rise in its non-brokered private placement offering. This development is not intended for distribution to United States newswire services or dissemination in the United States.",
            "link": "https://www.markets.news/headlines/8ee7e826-e91d-41b1-8c4e-52d231886e32",
            "pub_date": "2025-10-31 04:56:58",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Omnicom and Interpublic extend exchange offers in relation to anticipated merger closure by end of November.",
            "id": "1785b756-b9ae-489b-a25f-4d591c0d53ef",
            "description": "On October 30, 2025, Omnicom Group Inc. (\"Omnicom\") and The Interpublic Group of Companies, Inc. (\"IPG\") revealed plans for a merger that is anticipated to be finalized by the end of November. Both companies are listed on the New York Stock Exchange, with Omnicom trading under the ticker symbol OMC and IPG under IPG. The merger is set to bring together two major players in the industry, with the specifics of the deal expected to be disclosed as the closing date approaches.",
            "link": "https://www.markets.news/headlines/1785b756-b9ae-489b-a25f-4d591c0d53ef",
            "pub_date": "2025-10-31 04:57:01",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Stock of Strategy Inc. rises post-mixed Q3 results; 26% YTD Bitcoin yield; $8.42 EPS, $128.69M revenue - missed EPS but beat revenue estimates.",
            "id": "d6d5c8a9-2d01-43fd-abdc-8d57f93e9140",
            "description": "Strategy Inc., a company listed on NASDAQ under the ticker symbol MSTR, recently disclosed its third-quarter earnings post Thursday's market close. The financial figures revealed that the company's stock has experienced an increase. Strategy announced earnings of $8.42 per share for the quarter, falling short of the estimated $10.57 as per analysts. However, the quarterly revenue surpassed expectations, standing at $128.69 million compared to the estimated $118.43 million. For more insights, the full report can be found on Benzinga.com.",
            "link": "https://www.markets.news/headlines/d6d5c8a9-2d01-43fd-abdc-8d57f93e9140",
            "pub_date": "2025-10-31 04:59:25",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Spotless Brands appoints Matthew Schroeder as CFO & Jason O’Sullivan as SVP of IT to aid expansion into new markets.",
            "id": "4bf22106-04de-447a-8271-80c09bde199f",
            "description": "A company based in Oakbrook Terrace, Illinois, Spotless Brands, has recently announced the addition of two new members to their Executive Leadership team to aid in their expansion into new markets. Matthew Schroeder has joined as the Chief Financial Officer (CFO) and Jason O'Sullivan as the Senior Vice President (SVP) of Information Technology (IT). This strategic move aims to strengthen the team as they navigate growth, with the goal of reaching new markets.",
            "link": "https://www.markets.news/headlines/4bf22106-04de-447a-8271-80c09bde199f",
            "pub_date": "2025-10-31 04:51:13",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Robert Half declares $0.59 quarterly dividend per share, payable on Dec 15, 2025, to all RHI shareholders.",
            "id": "35b4e0d3-cad5-43d9-8995-f8e2b2ce998f",
            "description": "A company based in Menlo Park, California, Robert Half Inc. (NYSE: RHI), disclosed on October 30, 2025, that its board has sanctioned a quarterly cash dividend of $0.59 per share for its common stock. Shareholders of the company are set to receive this dividend on December 15, 2025.",
            "link": "https://www.markets.news/headlines/35b4e0d3-cad5-43d9-8995-f8e2b2ce998f",
            "pub_date": "2025-10-31 04:52:52",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "LEIFRAS Co., Ltd. (Nasdaq: LFS) disclosed unaudited financial results for the six months ending June 30, 2025.",
            "id": "8c22daf8-ac19-4f60-b2f1-87ed5894d0c6",
            "description": "Leifras Co., Ltd. (Nasdaq: LFS), based in Tokyo, revealed its unaudited financial results for the first half of 2025. The company, focused on youth sports and community involvement, announced this information on October 30, 2025. Specific financial figures for the six-month period ending on June 30, 2025, were shared, showcasing the company's performance in this time frame.",
            "link": "https://www.markets.news/headlines/8c22daf8-ac19-4f60-b2f1-87ed5894d0c6",
            "pub_date": "2025-10-31 04:52:54",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Vixxo hosts AI Hackathon in Scottsdale to innovate facilities management. 3-day event in 2025 brought together employees and students.",
            "id": "068636e7-c8eb-4ec2-b466-c0e2ab72d660",
            "description": "In Scottsdale, Arizona, Vixxo Facility Solutions recently organized an AI Innovation Hackathon at its headquarters, taking place from October 21 to 23, 2025. The event lasted for three days and saw participation from a range of employees spanning departments such as Operations, Supply Chain, Marketing, Client Success, IT Development, and Solutioning. In addition to employees, university students with outstanding skills also joined the event. Together, they worked on brainstorming and creating innovative solutions.",
            "link": "https://www.markets.news/headlines/068636e7-c8eb-4ec2-b466-c0e2ab72d660",
            "pub_date": "2025-10-31 04:55:26",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Sensient announces $0.41 per share dividend, payable on Dec 1, 2025, to shareholders on record by Nov 10, 2025.",
            "id": "ace5a02c-cd17-4ad9-9cbd-93c9e4ac06a8",
            "description": "The Board of Directors at Sensient Technologies Corporation (NYSE: SXT) has announced a regular quarterly cash dividend of $0.41 per share on its common stock. This dividend is scheduled to be paid on December 1, 2025, to shareholders holding stock as of the record date on November 10, 2025. Sensient Technologies Corporation is a prominent worldwide producer and distributor of colors, flavors, and specialty ingredients, utilizing innovative technologies and a strong global presence.",
            "link": "https://www.markets.news/headlines/ace5a02c-cd17-4ad9-9cbd-93c9e4ac06a8",
            "pub_date": "2025-10-31 04:46:02",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Advertising agency Bohan rebrands as Artists&Outlaws led by Shari Day in Nashville, TN.",
            "id": "1cf267fa-6db9-4c17-9e4f-bb6c8518dbb1",
            "description": "A renowned advertising agency in Nashville, Tennessee has undergone a rebranding, now known as Artists&Outlaws. This transformation is led by Shari Day, a seasoned advertising professional.",
            "link": "https://www.markets.news/headlines/1cf267fa-6db9-4c17-9e4f-bb6c8518dbb1",
            "pub_date": "2025-10-31 04:46:45",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        }
    ]
}